Informação sobre produto
- Apd668
APD 668 is an amide-based drug that has been shown to have clinical benefits in chronic treatment of type 2 diabetes. It has been shown to activate the glucagon-like peptide-1 receptor (GLP-1R) and increase the release of insulin. APD 668 decreases hepatic steatosis, insulin resistance, and inflammatory diseases associated with diabetes. APD 668 possesses pharmacokinetic properties that make it suitable for long-term treatment of type 2 diabetes. The drug is metabolized by esterases in plasma and tissues to form a fatty acid metabolite, which can be detected in plasma and urine. The drug also contains a hydroxyl group on the amide side chain that can react with benzyl groups in vivo to form a benzyloxycarbonyl derivative. This derivative is excreted into urine as a conjugate or as free metabolites.
APD 668 increases glucose levels but does not increase blood pressure.
Propriedades químicas
Consulta técnica sobre: 3D-FA103601 APD 668
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
